MMP9 and acute myeloid leukemia: In addition, AML and ALL patients who had elevated levels of matrix metalloproteinase-9 (MMP-9) and soluble vascular cell adhesion molecule 1 (sVCAM-1) in CSF were at risk of CNS involvement (Si et al., 2015).